iCAD (ICAD) Competitors $3.82 -0.14 (-3.54%) Closing price 04:00 PM EasternExtended Trading$3.82 0.00 (0.00%) As of 05:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ICAD vs. CLPT, SMLR, NNOX, SMTI, STIM, SNWV, ZIMV, TCMD, NVRO, and SKINShould you be buying iCAD stock or one of its competitors? The main competitors of iCAD include ClearPoint Neuro (CLPT), Semler Scientific (SMLR), Nano-X Imaging (NNOX), Sanara MedTech (SMTI), Neuronetics (STIM), SANUWAVE Health (SNWV), ZimVie (ZIMV), Tactile Systems Technology (TCMD), Nevro (NVRO), and Beauty Health (SKIN). These companies are all part of the "medical equipment" industry. iCAD vs. ClearPoint Neuro Semler Scientific Nano-X Imaging Sanara MedTech Neuronetics SANUWAVE Health ZimVie Tactile Systems Technology Nevro Beauty Health ClearPoint Neuro (NASDAQ:CLPT) and iCAD (NASDAQ:ICAD) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, media sentiment, profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation. Which has better earnings & valuation, CLPT or ICAD? iCAD has lower revenue, but higher earnings than ClearPoint Neuro. iCAD is trading at a lower price-to-earnings ratio than ClearPoint Neuro, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClearPoint Neuro$31.39M10.84-$22.09M-$0.76-16.00iCAD$19.53M5.37-$4.85M-$0.19-20.11 Do analysts rate CLPT or ICAD? ClearPoint Neuro presently has a consensus price target of $25.00, suggesting a potential upside of 105.59%. Given ClearPoint Neuro's stronger consensus rating and higher possible upside, analysts plainly believe ClearPoint Neuro is more favorable than iCAD.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ClearPoint Neuro 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00iCAD 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is CLPT or ICAD more profitable? iCAD has a net margin of -17.81% compared to ClearPoint Neuro's net margin of -59.64%. iCAD's return on equity of -15.65% beat ClearPoint Neuro's return on equity.Company Net Margins Return on Equity Return on Assets ClearPoint Neuro-59.64% -62.10% -38.39% iCAD -17.81%-15.65%-12.52% Does the MarketBeat Community prefer CLPT or ICAD? iCAD received 203 more outperform votes than ClearPoint Neuro when rated by MarketBeat users. However, 89.29% of users gave ClearPoint Neuro an outperform vote while only 59.84% of users gave iCAD an outperform vote. CompanyUnderperformOutperformClearPoint NeuroOutperform Votes2589.29% Underperform Votes310.71%iCADOutperform Votes22859.84% Underperform Votes15340.16% Does the media favor CLPT or ICAD? In the previous week, ClearPoint Neuro had 9 more articles in the media than iCAD. MarketBeat recorded 10 mentions for ClearPoint Neuro and 1 mentions for iCAD. ClearPoint Neuro's average media sentiment score of 0.30 beat iCAD's score of 0.23 indicating that ClearPoint Neuro is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ClearPoint Neuro 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral iCAD 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk and volatility, CLPT or ICAD? ClearPoint Neuro has a beta of 1.03, meaning that its share price is 3% more volatile than the S&P 500. Comparatively, iCAD has a beta of 1.35, meaning that its share price is 35% more volatile than the S&P 500. Do insiders and institutionals hold more shares of CLPT or ICAD? 30.1% of ClearPoint Neuro shares are held by institutional investors. Comparatively, 24.6% of iCAD shares are held by institutional investors. 7.0% of ClearPoint Neuro shares are held by company insiders. Comparatively, 10.3% of iCAD shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryClearPoint Neuro beats iCAD on 10 of the 18 factors compared between the two stocks. Get iCAD News Delivered to You Automatically Sign up to receive the latest news and ratings for ICAD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ICAD vs. The Competition Export to ExcelMetriciCADSurgical & medical instruments IndustryComputer SectorNASDAQ ExchangeMarket Cap$104.84M$4.47B$25.08B$8.38BDividend YieldN/A43.64%2.90%4.10%P/E Ratio-29.3829.4344.6019.71Price / Sales5.3767.722,088.05117.39Price / CashN/A51.0834.7834.62Price / Book3.016.236.654.50Net Income-$4.85M$68.16M$739.99M$248.18M7 Day Performance-2.30%18.33%-0.99%1.14%1 Month Performance26.07%23.04%14.39%15.20%1 Year Performance134.36%20.61%52,549.95%6.56% iCAD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ICADiCAD0.2843 of 5 stars$3.82-3.5%N/A+141.5%$104.84M$19.53M-29.38140News CoverageAnalyst ForecastGap UpCLPTClearPoint Neuro1.7237 of 5 stars$13.64-3.3%$25.00+83.3%+108.6%$381.65M$31.39M-19.77110Positive NewsGap UpSMLRSemler Scientific2.5481 of 5 stars$34.84+0.1%$71.00+103.8%+78.4%$334.36M$56.29M7.10120Positive NewsOptions VolumeGap UpHigh Trading VolumeNNOXNano-X Imaging1.4304 of 5 stars$5.56+6.1%$12.00+115.8%-43.7%$321.25M$11.28M-6.54190News CoverageUpcoming EarningsGap UpSMTISanara MedTech1.7872 of 5 stars$34.37+6.2%$48.50+41.1%-4.6%$305.48M$86.67M-34.7260Earnings ReportAnalyst RevisionHigh Trading VolumeSTIMNeuronetics1.7482 of 5 stars$4.14-6.5%$5.50+32.9%+69.6%$272.47M$74.89M-3.37180SNWVSANUWAVE HealthN/A$30.55+1.5%N/AN/A$261.17M$32.63M-6.7040ZIMVZimVie2.196 of 5 stars$8.91+1.7%$19.50+118.9%-47.9%$248.12M$449.75M-0.682,700TCMDTactile Systems Technology3.3801 of 5 stars$9.72+1.9%$16.00+64.6%-23.8%$230.03M$292.98M13.89980NVRONevro0.1931 of 5 stars$5.85+0.1%$5.36-8.3%-44.4%$224.32M$408.52M-3.091,090News CoverageSKINBeauty Health0.3638 of 5 stars$1.76-5.9%$2.45+39.2%-34.7%$220.43M$322.47M-4.191,030Trending NewsHigh Trading Volume Related Companies and Tools Related Companies ClearPoint Neuro Alternatives Semler Scientific Alternatives Nano-X Imaging Alternatives Sanara MedTech Alternatives Neuronetics Alternatives SANUWAVE Health Alternatives ZimVie Alternatives Tactile Systems Technology Alternatives Nevro Alternatives Beauty Health Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ICAD) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iCAD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iCAD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ICAD Stock Free ICAD Stock Alerts